# Madrigal Pharmaceuticals, Inc.: Form SC 13D/A, filed Nov 21, 2023

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: SC 13D/A
- Filed: 2023-11-21
- Accepted by EDGAR: Nov 21, 2023, 17:24 ET
- Period: not reported
- Accession: 0001104659-23-120429
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000110465923120429/tm2331311d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000110465923120429/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000110465923120429/tm2331311d1_sc13da.htm

Filed Nov 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-120429. Last ingested by Listed: Nov 6, 2026, 18:49 ET. No prices; not investment advice.